Dr. Garrett is Chief Operating Officer / Chief Scientific Officer at AptamiR Therapeutics. Following an accomplished academic career at the University of Adelaide and the University of Texas he held senior positions at Tutume Consulting, Zimmer Biomet, Surgacoll, Elk Biologics and OsteoScreen overseeing drug-device R&D development and operations. Dr Garrett has a PhD in Pathology, MSc in Physiology, BSc in Biochemistry and Organic Chemistry from the University of Adelaide, a degree in Medical Technology from Uni of South Australia and a postgraduate fellowship in Endocrinology at the University of Texas Health Science Center. He currently holds an appointment as Associate Professor at University of Texas.
Marc Thibonnier, M.D., M.Sc.
- Dr. Thibonnier is the Founder and President of AptamiR Therapeutics, Inc. As a Physician-Scientist, he led a successful career in academic medicine in France and the USA up to the rank of tenured Professor of Medicine and Pharmacology, followed by several years in executive leadership positions at major Pharmaceutical Companies (Bayer Health Care, BMS, and GSK) and two Biotechnology Startup Companies, overseeing cardiovascular and metabolic drugs development from candidate selection to regulatory approval.
- Dr. Thibonnier earned a M.D. degree with High Honors from the Université Pierre et Marie Curie in Paris, France and a M.Sc. in Pharmacology from the University of California, San Francisco where he completed his fellowship in clinical pharmacology. He trained in Endocrinology, Nephrology and Clinical Pharmacology.